Pipelines

Research Pipelines

RBI-01

12-plant, non-opioid herbal formulation (approved supplement).

RBI-02

Novel T-type calcium channel antagonists.

RBI-03

Novel, nature-inspired dopamine modulator.

Resilience Bioscience Inc. (RBI) is developing herbal and small-molecule therapeutics for major unmet clinical needs – opioid withdrawal and associated hyperalgesia, and cognitive deficits in the context of neuropsychiatric disorders.